N W Schluger

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi Tuberculosis
    Neil W Schluger
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, New York 10032, USA
    Semin Respir Crit Care Med 29:465-6. 2008
  2. ncbi Recent advances in testing for latent TB
    Neil W Schluger
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, NY 10032, USA
    Chest 138:1456-63. 2010
  3. ncbi Eosinophil and T cell markers predict functional decline in COPD patients
    JEANINE M D'ARMIENTO
    Department of Medicine, Columbia University, New York, NY, USA
    Respir Res 10:113. 2009
  4. ncbi Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients
    N W Schluger
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Clin Infect Dis 28:130-5. 1999
  5. ncbi Suppose they gave an epidemic and nobody came?
    Neil W Schluger
    Columbia University Medical Center, PH 9 East, Room 101, 622 West 168th Street, New York, NY 10032, USA
    Am J Bioeth 8:23-5. 2008
  6. ncbi Tuberculosis drug resistance in Europe: sunny days, but clouds on the horizon?
    N W Schluger
    Columbia University Medical Center, New York, NY 10032, USA
    Eur Respir J 30:825-7. 2007
  7. ncbi Tuberculosis and nontuberculous mycobacterial infections in older adults
    Neil W Schluger
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, Epidemiology and Environmental Health Sciences, Mailman School of Public Health, 722 West 168th Street, New York, NY 10032, USA
    Clin Chest Med 28:773-81, vi. 2007
  8. ncbi The pathogenesis of tuberculosis: the first one hundred (and twenty-three) years
    Neil W Schluger
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, PH-8E, Room 101, 622 West 168th Street, New York, NY 10032, USA
    Am J Respir Cell Mol Biol 32:251-6. 2005
  9. ncbi Recent advances in our understanding of human host responses to tuberculosis
    N W Schluger
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    Respir Res 2:157-63. 2001
  10. ncbi Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy
    Neil W Schluger
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Chest 122:597-602. 2002

Research Grants

  1. Mentoring in Tuberculosis Patient-Oriented Research
    Neil Schluger; Fiscal Year: 2007
  2. Training in Translational Lung Research
    Neil Schluger; Fiscal Year: 2007

Collaborators

Detail Information

Publications28

  1. ncbi Tuberculosis
    Neil W Schluger
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, New York 10032, USA
    Semin Respir Crit Care Med 29:465-6. 2008
  2. ncbi Recent advances in testing for latent TB
    Neil W Schluger
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, NY 10032, USA
    Chest 138:1456-63. 2010
    ....
  3. ncbi Eosinophil and T cell markers predict functional decline in COPD patients
    JEANINE M D'ARMIENTO
    Department of Medicine, Columbia University, New York, NY, USA
    Respir Res 10:113. 2009
    ..We therefore measured cytokine levels in the lung lavage fluid and plasma of COPD patients in order to determine if the levels of T cell or eosinophil related cytokines were predictive of the future course of the disease...
  4. ncbi Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients
    N W Schluger
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Clin Infect Dis 28:130-5. 1999
    ..This will require careful coordination of antituberculosis and antiretroviral therapies...
  5. ncbi Suppose they gave an epidemic and nobody came?
    Neil W Schluger
    Columbia University Medical Center, PH 9 East, Room 101, 622 West 168th Street, New York, NY 10032, USA
    Am J Bioeth 8:23-5. 2008
  6. ncbi Tuberculosis drug resistance in Europe: sunny days, but clouds on the horizon?
    N W Schluger
    Columbia University Medical Center, New York, NY 10032, USA
    Eur Respir J 30:825-7. 2007
  7. ncbi Tuberculosis and nontuberculous mycobacterial infections in older adults
    Neil W Schluger
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, Epidemiology and Environmental Health Sciences, Mailman School of Public Health, 722 West 168th Street, New York, NY 10032, USA
    Clin Chest Med 28:773-81, vi. 2007
    ..More than 8 million people every year develop active tuberculosis disease, and 2 million die as a result. This article reviews tuberculosis and nontuberculous mycobacterial infections in older adults...
  8. ncbi The pathogenesis of tuberculosis: the first one hundred (and twenty-three) years
    Neil W Schluger
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, PH-8E, Room 101, 622 West 168th Street, New York, NY 10032, USA
    Am J Respir Cell Mol Biol 32:251-6. 2005
  9. ncbi Recent advances in our understanding of human host responses to tuberculosis
    N W Schluger
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    Respir Res 2:157-63. 2001
    ..The role of key cytokines such as interferon-gamma is discussed, as is the role of CD4+ and CD8+ T cells in immune regulation in tuberculosis, particularly with regard to implications for vaccine development and evaluation...
  10. ncbi Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy
    Neil W Schluger
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Chest 122:597-602. 2002
    ....
  11. ncbi Tuberculosis and HIV infection: epidemiology, immunology, and treatment
    N W Schluger
    The Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    HIV Clin Trials 2:356-65. 2001
    ....
  12. ncbi The diagnosis of tuberculosis: what's old, what's new
    Neil W Schluger
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, Mailman School of Public Health of Columbia University, New York, NY, USA
    Semin Respir Infect 18:241-8. 2003
    ..However, economic analyses suggest that these assays can be cost effective if they lead to sharp reductions in transmission through earlier treatment of infectious cases...
  13. ncbi Analysis of hospitalizations for COPD exacerbation: opportunities for improving care
    Natalie H Yip
    Division of Pulmonary, Allergy and Critical Care, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    COPD 7:85-92. 2010
    ..We hypothesized that there are substantial opportunities for improvement in adherence with current guidelines and recommendations...
  14. ncbi DOT and timely treatment completion among Asian-born immigrant tuberculosis patients
    S Y Liu
    Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 10023, USA
    Int J Tuberc Lung Dis 9:884-9. 2005
    ..A large urban tuberculosis (TB) control program...
  15. ncbi Changes in the transmission of tuberculosis in New York City from 1990 to 1999
    Elvin Geng
    College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    N Engl J Med 346:1453-8. 2002
    ..S.-born persons, many cases result from recent transmission. Strategies for the control and elimination of tuberculosis among foreign-born persons at high risk should be directed toward the treatment of latent tuberculosis infection...
  16. ncbi Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study
    Elvin Geng
    College of Physicians and Surgeons, Columbia University, New York, NY, USA
    JAMA 293:2740-5. 2005
    ..The altered radiographic appearance of pulmonary tuberculosis in HIV is due to altered immunity rather than recent acquisition of infection and progression to active disease...
  17. ncbi Tuberculosis following solid organ transplantation
    D Lopez de Castilla
    Department of Epidemiology and Environmental Health Sciences, Columbia University College of Physicians and Surgeons, Columbia University Medical Center, New York, New York 10032, USA
    Transpl Infect Dis 12:106-12. 2010
    ..Organ transplantation places patients at risk for tuberculosis (TB), which constitutes a challenge to physicians due to its atypical and extrapulmonary presentations, complicated treatment issues, and high morbidity and mortality...
  18. ncbi Transmission trends for human immunodeficiency virus associated tuberculosis in New York City
    E H Geng
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Int J Tuberc Lung Dis 9:661-6. 2005
    ..Since 1992, tuberculosis (TB) control measures have reduced incidence rates in New York City and elsewhere. Nevertheless, trends have not been uniform in all demographic groups...
  19. ncbi Regional deposition of aerosolized interferon-gamma in pulmonary tuberculosis
    Rany Condos
    Bellevue Chest Service, Division of Pulmonary and Critical Care Medicine, NYU School of Medicine, New York, USA
    Chest 125:2146-55. 2004
    ..The objective of the current study was to evaluate particle size and deposition pattern in patients with TB receiving aerosol IFN-gamma treatment...
  20. ncbi Use of an interferon-gamma release assay to diagnose latent tuberculosis infection in foreign-born patients
    Daniel Brodie
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, NY 10032, USA
    Chest 133:869-74. 2008
    ..We sought to validate the routine clinical use of the T-SPOT.TB test (Oxford Immunotec; Oxford, UK), an IGRA, in a predominantly foreign-born population with a high rate of BCG vaccination...
  21. ncbi Effect of nucleic acid amplification for Mycobacterium tuberculosis on clinical decision making in suspected extrapulmonary tuberculosis
    Renda Soylemez Wiener
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia Presbyterian Medical Center, 630 West 168th St, New York, NY 10032, USA
    Chest 128:102-7. 2005
    ..Judicious use of these tests may improve the accuracy and speed of diagnosis of extrapulmonary tuberculosis, while helping to eliminate unnecessary antituberculous treatment in patients without tuberculosis...
  22. ncbi Preventing the next generation of extensively drug-resistant tuberculosis
    Y Ben Amor
    Millennium Villages Project, The Earth Institute at Columbia University, New York, New York 10027, USA
    Int J Tuberc Lung Dis 14:525-7. 2010
    ..Widespread use of new drugs as first-line agents would follow with the dawn of a new rapid diagnostic era...
  23. ncbi Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City
    Ethan E Bodle
    Columbia University, New York, New York, USA
    Emerg Infect Dis 14:390-6. 2008
    ..avium complex (MAC) (27%, (p < 0.01). NTM disease in patients without HIV is increasing. Laboratory-based surveillance may be useful for detecting non-MAC and non-respiratory tract disease...
  24. ncbi The epidemiology of tuberculosis in the United States
    Joseph Burzynski
    Columbia University College of Physicians and Surgeons, New York, New York, USA
    Semin Respir Crit Care Med 29:492-8. 2008
    ....
  25. ncbi The diagnosis of tuberculosis
    Daniel Brodie
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, 622 West 168th Street, PH 8 East, Room 101, New York, NY 10032, USA
    Clin Chest Med 26:247-71, vi. 2005
    ..The appropriate and affordable use of any of these tests depends on the setting in which they are employed...
  26. ncbi Assessing tuberculosis transmission and virulence: the vanishing tuberculin skin test
    Neil W Schluger
    Am J Respir Crit Care Med 173:942-3. 2006
  27. ncbi Challenges of treating latent tuberculosis infection
    Neil W Schluger
    Chest 121:1733-5. 2002
  28. ncbi Feasibility of retinoids for the treatment of emphysema study
    Michael D Roth
    Division of Pulmonary and Critical Care, University of California, Los Angeles, CA 90095 1690, USA
    Chest 130:1334-45. 2006
    ..Retinoids promote alveolar septation in the developing lung and stimulate alveolar repair in some animal models of emphysema...

Research Grants4

  1. Mentoring in Tuberculosis Patient-Oriented Research
    Neil Schluger; Fiscal Year: 2007
    ..abstract_text> ..
  2. Training in Translational Lung Research
    Neil Schluger; Fiscal Year: 2007
    ..abstract_text> ..